Trial NCT03149159

View at ClinicalTrials.gov 
Org. Study IDs: 102576
Secondary IDs: CA209-927

Last trial update was posted on 2018-06-18

MeSH Interventions

Ipilimumab Nivolumab

MeSH Conditions

Carcinoma Carcinoma, Renal Cell

Other Conditions

Clear Cell Renal Cell Carcinoma Metastatic Renal Cell Carcinoma

Stopping Reasons

This study is withdrawn due to feasibility issues.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID